The Cancer Letter

Inside information on cancer research and drug development

In Brief

Lynda Carter Altman establishes fund for City of Hope and TGen to support research in sAML diagnostics and treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Lynda Carter Altman and Robert Altman

The Translational Genomics Research Institute, part of City of Hope, formed a partnership with actress, singer-songwriter, and advocate, Lynda Carter Altman, to accelerate diagnostics and treatments, including precision medicine approaches, for secondary acute myeloid leukemia.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.
Table of Contents

Login

Looking for IP Login?